In my lab we have developed strategies to generate engineered airway tissue for disease modeling, drug testing and transplantation. This research has included the development of techniques and tools such as patient-specific induced pluripotent stem cells, airway and lung tissue deceullarization, extracellular matrix hydrogels, and 3D bioprinting technology. The outcomes of this multidisciplinary approach include the fabrication of patient specific airway constructs for transplantation, “disease-in-a-dish” approaches to cystic fibrosis disease modeling, and microfluidic lung-on-a-chip organoids for the high throughput screening and evaluation of novel drugs and small molecule therapies for patients with lung disease.
Education Program Involvement
Biomedical Engineering PhD